Search Results 1-10 of 12977 for NMN

  2. Chemotherapy-induced cognitive impairment: A potential preventive strategy - Mayo Clinic

    This indicates that NMN may be a safe and promising compound for CICI ," says Mi Hyeon (Mi-Hyeon) Jang, Ph.D., director of the Neurogenesis and Brain Repair ...

  3. Nicotinamide Riboside Supplementation and Aging on Altitude Acclimatization - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Mayo Clinic Researchers Link Specific Enzyme to Process of Metabolic Dysfunction in Aging

    — Researchers at Mayo Clinic have identified the enzyme, called CD38, that is responsible for the decrease in nicotinamide adenine dinucleotide (NAD) during ...

  5. A Study Evaluating The Use Of 31P MRS To Assess Brain NAD+ Levels As Compared To Nicotinamide Riboside Supplementation In Healthy Current And Former Collegiate Athletes - Mayo Clinic

    The purpose of this study is to determine if nicotinamide riboside (750 mg/day for 12 weeks) can affect the levels of NAD+ in the brain as measured by 31P MRS.

  6. A Study With NVC-001 In Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Malignant peripheral nerve sheath tumors (MPNSTs) - Symptoms and causes - Mayo Clinic

    These cancers form in the covering on nerves. Treatment includes surgery, radiation therapy and, sometimes, chemotherapy.

  8. Study Of ALXN1920 In Adult Participants With Primary Membranous Nephropathy (PMN) - Mayo Clinic

    The primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease ...

  9. https://www.mayoclinic.org/spanish_organization_concepts.xml

  10. AAO 2022

    A Large Case Series of Patients With Ocular Neuromyotonia: Clinical. Features, Diagnostic Pitfalls and Outcomes. John Chen, MD, Michael Brodsky, MD, ...